Shyamasundaran Kottilil is an Infectious Disease physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 119 publications with 4,298 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22 S Greene St
Baltimore, MD 212011544
Telephone
410-706-4613Provider last certified this registry record 19 May 2026.
Clinical trials
- Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4
Sponsor: University of Maryland, Baltimore
- Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- Gilead Sciences, Inc.Program year20241 payment
- Regeneron Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Impact of opioid use disorder on mitochondrial dysfunction among antiretroviral therapy-receiving aging people with HIV.
University of Maryland Baltimore
FY2026$685,937R01DA065079 - Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs
University of Maryland Baltimore
FY2021$519,525R01DA043396 - Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs
University of Maryland Baltimore
FY2020$365,025R01DA043396
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”